Clinical Study on the Immunomodulatory Effect of Eprolidone on Patients With Chronic Heart Failure
Clinical trial NCT05924958 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05924958
- Sponsor
- Cheng LuFeng,Principal Investigator
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2026-08-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.